Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
6421
Data_Sheet_3_Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.PDF
Published 2022“…</p>Results<p>This meta-analysis included 30 randomized controlled trials (RCTs) with a total of 1,201 patients. Six primary outcomes and six secondary outcomes were analyzed. …”
-
6422
-
6423
Data_Sheet_1_Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.PDF
Published 2022“…</p>Results<p>This meta-analysis included 30 randomized controlled trials (RCTs) with a total of 1,201 patients. Six primary outcomes and six secondary outcomes were analyzed. …”
-
6424
Engineering a Highly Defective Stable UiO-66 with Tunable Lewis- Brønsted Acidity: The Role of the Hemilabile Linker
Published 2020“…Herein, we use a hemilabile (Hl) linker to create up to a maximum of six defects per cluster in UiO-66. …”
-
6425
Data_Sheet_5_Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.PDF
Published 2022“…</p>Results<p>This meta-analysis included 30 randomized controlled trials (RCTs) with a total of 1,201 patients. Six primary outcomes and six secondary outcomes were analyzed. …”
-
6426
Data_Sheet_4_Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.PDF
Published 2022“…</p>Results<p>This meta-analysis included 30 randomized controlled trials (RCTs) with a total of 1,201 patients. Six primary outcomes and six secondary outcomes were analyzed. …”
-
6427
Data_Sheet_2_Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis.PDF
Published 2022“…</p>Results<p>This meta-analysis included 30 randomized controlled trials (RCTs) with a total of 1,201 patients. Six primary outcomes and six secondary outcomes were analyzed. …”
-
6428
Image_1_Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure.jpg
Published 2022“…In adjusted mixed models, functional progression of glaucoma damage was associated with VIMmap (−2.57 dB change in MD per every 3 mmHg increase in VIMmap; P < 0.001) and diurnal MAP dips (changes in the MD ranged from −2.56 to −3.19 dB; P < 0.001). Every 5 mmHg decrease in the nocturnal MAP level was associated with −1.14 dB changes in MD [95% confidence interval (CI), −1.90 to −0.40] and 0.01 larger optic disc cupping (95% CI, 0.01–0.02). …”
-
6429
DataSheet1_Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole.docx
Published 2021“…Furthermore, CYP2C19*17 mutants could strengthen the effects of glucocorticoids and decrease VRC C<sub>min</sub>/dose to a larger extent.…”
-
6430
Table_1_Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure.doc
Published 2024“…In adjusted mixed models, functional progression of glaucoma damage was associated with VIMmap (−2.57 dB change in MD per every 3 mmHg increase in VIMmap; P < 0.001) and diurnal MAP dips (changes in the MD ranged from −2.56 to −3.19 dB; P < 0.001). Every 5 mmHg decrease in the nocturnal MAP level was associated with −1.14 dB changes in MD [95% confidence interval (CI), −1.90 to −0.40] and 0.01 larger optic disc cupping (95% CI, 0.01–0.02). …”
-
6431
Data Sheet 1_The promotion effect of FeS2 on Sb2S3 bioleaching and Sb speciation transformation.docx
Published 2025“…The DFT results show that between the Sb<sub>2</sub>S<sub>3</sub> (0 1 0) and FeS<sub>2</sub> (1 0 0) surfaces, S-Fe, S-S, S-Sb, and Sb-Fe bonds are formed, and the direction of electron transfer is from Sb<sub>2</sub>S<sub>3</sub> to FeS<sub>2</sub>; the work functions for Sb<sub>2</sub>S<sub>3</sub> after addition of FeS<sub>2</sub> decrease, implying that faster electron transfer occurs; Fe(III)-6H<sub>2</sub>O derived from FeS<sub>2</sub> adsorbs on the surface more easily than does glucose, which is the major component of the extracellular polymeric substances in bacteria, indicating that during the bioleaching process, Fe(III)-6H<sub>2</sub>O plays an important role; after mixing, both Fe(III)-6H<sub>2</sub>O and glucose adsorb on the Sb<sub>2</sub>S<sub>3</sub> (0 1 0) surface more easily, with stronger bonds and larger adsorption energies, which are in good agreement with the experimental results.…”
-
6432
Image_1_Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure.jpg
Published 2024“…In adjusted mixed models, functional progression of glaucoma damage was associated with VIMmap (−2.57 dB change in MD per every 3 mmHg increase in VIMmap; P < 0.001) and diurnal MAP dips (changes in the MD ranged from −2.56 to −3.19 dB; P < 0.001). Every 5 mmHg decrease in the nocturnal MAP level was associated with −1.14 dB changes in MD [95% confidence interval (CI), −1.90 to −0.40] and 0.01 larger optic disc cupping (95% CI, 0.01–0.02). …”
-
6433
Table_1_Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure.doc
Published 2022“…In adjusted mixed models, functional progression of glaucoma damage was associated with VIMmap (−2.57 dB change in MD per every 3 mmHg increase in VIMmap; P < 0.001) and diurnal MAP dips (changes in the MD ranged from −2.56 to −3.19 dB; P < 0.001). Every 5 mmHg decrease in the nocturnal MAP level was associated with −1.14 dB changes in MD [95% confidence interval (CI), −1.90 to −0.40] and 0.01 larger optic disc cupping (95% CI, 0.01–0.02). …”
-
6434
-
6435
Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach
Published 2015“…Data analysis revealed 59 urinary proteins that were significantly different in breast cancer patients compared to the normal control subjects (<i>p</i><0.05, fold change >3). Thirty-six urinary proteins were exclusively found in specific breast cancer stages, with 24 increasing and 12 decreasing in their abundance. …”
-
6436
Data Sheet 1_Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective study.pdf
Published 2025“…Following six months of INH prophylaxis, significant reductions in these markers were observed in both groups, suggesting a reduction in inflammation.…”
-
6437
Table_1_Lipids, lipid-modified drug target genes, and the risk of male infertility: a Mendelian randomization study.xlsx
Published 2024“…The HMGCR inhibitor (equivalent to a 1-SD decrease in LDL-C) was associated with a lower risk of MIF (OR=0.38, 95% CI 0.17-0.83, FDR=0.39). …”
-
6438
Data Sheet 1_Urinary microbiota changes among NMIBC patients during BCG therapy: comparing BCG responders and non-responders.docx
Published 2025“…Emerging evidence suggests that urinary microbiota may play a crucial role in BCG efficacy. This study aimed to explore (i) changes in urinary microbiota during the six induction cycles of BCG and (ii) its potential predictive role in determining the outcome of BCG treatment. …”
-
6439
Table_1_Cancer Related Subarachnoid Hemorrhage: A Multicenter Retrospective Study Using Propensity Score Matching Analysis.XLSX
Published 2022“…Logistic regression was applied to investigate the independent risk factors of SAH in patients with active cancer, after a 1:1 propensity score matching (PSM). A receiver operator characteristic curve was configured to calculate the optimal cut-off value of the joint predictive factor for cancer related SAH.…”
-
6440